Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02119663
Title A Study of Ruxolitinib in Pancreatic Cancer Patients
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors Incyte Corporation
Indications
Therapies
Age Groups: adult
Covered Countries USA | NLD | FRA | AUT

Facility Status City State Zip Country Details
Huntsville Alabama United States Details
Fayetteville Arkansas United States Details
Beverly Hills California United States Details
La Jolla California United States Details
Aurora Colorado United States Details
Denver Colorado United States Details
Washington District of Columbia United States Details
Fort Myers Florida United States Details
Saint Petersburg Florida United States Details
Athens Georgia United States Details
Atlanta Georgia United States Details
Macon Georgia United States Details
Thomasville Georgia United States Details
Harvey Illinois United States Details
Indianapolis Indiana United States Details
Kansas City Kansas United States Details
Louisville Kentucky United States Details
Baltimore Maryland United States Details
Boston Massachusetts United States Details
Farmington Hills Michigan United States Details
Kalamazoo Michigan United States Details
Lansing Michigan United States Details
Minneapolis Minnesota United States Details
Saint Louis Park Minnesota United States Details
Bolivar Missouri United States Details
Basking Ridge New Jersey United States Details
Cherry Hill New Jersey United States Details
Voorhees New Jersey United States Details
Commack New York United States Details
Fresh Meadows New York United States Details
Harrison New York United States Details
New York New York United States Details
Rochester New York United States Details
Rockville Centre New York United States Details
Sleepy Hollow New York United States Details
Canton Ohio United States Details
Cincinnati Ohio United States Details
Portland Oregon United States Details
Allentown Pennsylvania United States Details
Hershey Pennsylvania United States Details
Langhorne Pennsylvania United States Details
Greenville South Carolina United States Details
Chattanooga Tennessee United States Details
Knoxville Tennessee United States Details
Nashville Tennessee United States Details
Dallas Texas United States Details
Fort Worth Texas United States Details
Lubbock Texas United States Details
San Antonio Texas United States Details
Temple Texas United States Details
Salt Lake City Utah United States Details
Falls Church Virginia United States Details
Newport News Virginia United States Details
Seattle Washington United States Details
Green Bay Wisconsin United States Details
Graz Austria Details
Linz Austria Details
Salzburg Austria Details
Vienna Austria Details
Wein Austria Details
Santiago Chile Details
Vitacura Chile Details
Bogota Colombia Details
Medellin Colombia Details
Naestved Denmark Details
Odense C Denmark Details
Bordeaux France Details
Brest Cedex France Details
Dijon France Details
Lyon France Details
Nancy France Details
Cork Ireland Details
Dubin Ireland Details
Galway Ireland Details
Beer Sheva Israel Details
Haifa Israel Details
Jerusalem Israel Details
Petach Tikva Israel Details
Ramat Gan Israel Details
Tel Aviv Israel Details
Tel Hashomer Israel Details
Monterrey Mexico Details
Oaxaca Mexico Details
Toluca Mexico Details
Amsterdam Netherlands Details
Maastricht Netherlands Details
Nijmegen Netherlands Details
Braga Portugal Details
Lisboa Portugal Details
Porto Portugal Details
San Juan Puerto Rico Details
Linköping Sweden Details
Uppsala Sweden Details
Bellinzona Switzerland Details
Geneve Switzerland Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field